ANTSO Board role for Provost
The announcements were recently made by ANTSO CEO, Dr Adi Paterson.
Professor Sheil has been the Provost at the University of Melbourne since April 2012, and has previously held significant positions across numerous committees, advisory boards, and specialist technical institutes.
She was CEO of the Australian Research Council for five years, and prior to that was Deputy Vice Chancellor (Research), Dean of Science and a Professor of Chemistry at the University of Wollongong.
Dr Paterson said the depth and breadth of both new board members’ work histories across the science, health and research sectors in Australia and abroad would bring invaluable insights to ANSTO.
“Professor Sheil and Professor Heywood join the board at an exciting time for ANSTO,” she said.
“ANSTO will soon support the world’s nuclear medicine supply, as construction of our ANM facility reaches its last phases, before going into operation next year.
"By the end of next year it will have ramped up to full production, producing some 10 million doses of Molybdenum-99 (Mo-99), which is 25 per cent of world supply, annually. Nuclear medicine is a cornerstone of medical systems, particularly Technetium-99m (Tc-99m), which is derived from Molybdenum-99 (Mo-99) and used to diagnose heart, lung and skeletal conditions and a range of cancers.
“In addition, the Australian Synchrotron has joined ANSTO as another research platform, cementing our role as home to much of Australia’s landmark science infrastructure and research that is focused on health, environment and supporting Australian industries”.
For more information click here.